A Randomized Phase 1 Food-Effect Study of H3B-6527 in Healthy Subjects
Latest Information Update: 28 Nov 2019
At a glance
- Drugs H3B 6527 (Primary)
- Indications Cholangiocarcinoma; Liver cancer
- Focus Pharmacokinetics
- Sponsors Eisai Inc
- 09 Feb 2018 New trial record